Clinical trial
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in…
NCT00492232 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00492232 |
|---|---|
| Title | Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia |
| Official title | Randomized, Double Blind, Placebo-Controlled Study to Assess Whether the Administration of Ramelteon Could Facilitate the Discontinuation of Zolpidem (Ambien®) ≥10 mg Therapy in Subjects With Chronic Insomnia |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Insomnia |
| Intervention type | Drug |
| Interventions | Ramelteon and zolpidem, Placebo and zolpidem |
| Enrollment | 135 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Jul 20, 2010 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: